Free Trial
NASDAQ:IVA

Inventiva (IVA) Stock Price, News & Analysis

Inventiva logo
$3.46 +0.44 (+14.57%)
Closing price 07/8/2025 03:46 PM Eastern
Extended Trading
$3.34 -0.12 (-3.32%)
As of 08:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Inventiva Stock (NASDAQ:IVA)

Key Stats

Today's Range
$3.20
$3.69
50-Day Range
$2.98
$3.70
52-Week Range
$1.53
$4.05
Volume
79,111 shs
Average Volume
64,312 shs
Market Capitalization
$330.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.40
Consensus Rating
Moderate Buy

Company Overview

Inventiva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

IVA MarketRank™: 

Inventiva scored higher than 55% of companies evaluated by MarketBeat, and ranked 456th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inventiva has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Inventiva has received no research coverage in the past 90 days.

  • Read more about Inventiva's stock forecast and price target.
  • Percentage of Shares Shorted

    0.05% of the float of Inventiva has been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently decreased by 90.87%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Inventiva does not currently pay a dividend.

  • Dividend Growth

    Inventiva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.05% of the float of Inventiva has been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently decreased by 90.87%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Inventiva this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    5 people have added Inventiva to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inventiva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.00% of the stock of Inventiva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.06% of the stock of Inventiva is held by institutions.

  • Read more about Inventiva's insider trading history.
Receive IVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter.

IVA Stock News Headlines

Inventiva receives $10 million milestone payment from CTTQ
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

IVA Stock Analysis - Frequently Asked Questions

Inventiva's stock was trading at $2.14 at the start of the year. Since then, IVA stock has increased by 61.7% and is now trading at $3.46.

Inventiva (IVA) raised $103 million in an initial public offering on Friday, July 10th 2020. The company issued 7,500,000 shares at a price of $13.68 per share. Jefferies, Stifel and Guggenheim Securities acted as the underwriters for the IPO and H.C. Wainwright, Roth Capital Partners and KBC Securities were co-managers.

Shares of IVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inventiva investors own include Kinross Gold (KGC), Oncobiologics (OTLK), Accuray (ARAY), Carnival (CCL), Alibaba Group (BABA), PayPal (PYPL).

Company Calendar

Today
7/08/2025
Next Earnings (Estimated)
9/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IVA
CIK
1756594
Fax
N/A
Employees
100
Year Founded
2011

Price Target and Rating

High Price Target
$17.00
Low Price Target
$3.00
Potential Upside/Downside
+200.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.95 million
Price / Cash Flow
N/A
Book Value
($1.21) per share
Price / Book
-2.86

Miscellaneous

Free Float
65,050,000
Market Cap
$330.98 million
Optionable
Not Optionable
Beta
0.73

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:IVA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners